Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIDOTETRA: Lidocaine-Tetracaine Gel vs EMLA for Wound Debridement
NCT05890703Phase 2Unknown
- Start
- Jun 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine 10% oropharyngeal spray, tetracaine in leg ulcer. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spraytetracaine
03
Conditions
leg ulcer
Beyond the preview
Go deeper on NCT05890703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05890703.